Portfolio Advancing Portfolio Screening Program RFP Year2017 Awarded Amount $65,836 DiseaseMalaria InterventionDrug Development Stage Hit Identification Collaboration Partners Astellas Pharma Inc., Medicines for Malaria Venture (MMV)